[Biopsy transcriptome in kidney transplantation : ready for primetime ?]

Area of Science:

• Nephrology
• Transplantation immunology
• Genomics

Background:

• Kidney graft biopsy is the primary method for diagnosing disease in kidney transplantation.
• Current biopsy methods face limitations, notably interobserver variability, impacting diagnostic accuracy.
• Intragraft transcriptomics is emerging as a powerful tool for biomarker research in transplantation.

Purpose of the Study:

• To explore the potential of intragraft transcriptomics for enhanced disease stratification in kidney transplantation.
• To address the need for improved diagnostic tools beyond traditional biopsy methods.
• To investigate the role of transcriptomics in complementing existing diagnostic classifications.

Main Methods:

• Analysis of intragraft gene expression profiles in kidney transplant recipients.
• Comparison of transcriptomic data with traditional biopsy findings.
• Evaluation of transcriptomics as a biomarker for disease classification.

Main Results:

• Intragraft transcriptomics offers potential for improved stratification of kidney transplant diseases.
• The Banff classification has incorporated transcriptomics, but clinical utility needs external validation.
• Transcriptomic data may be enhanced by integration with other omics datasets.

Conclusions:

• Intragraft transcriptomics represents a significant advancement in kidney transplantation diagnostics.
• Further validation studies are crucial for the clinical integration of transcriptomics.
• Combining transcriptomics with other omics data may optimize diagnostic and prognostic capabilities.